Vironix was formed by a group of passionate scientists, physicians, technologists, and entrepreneurs who have amassed decades of research, development, and commercialization expertise in machine-learned applications, respiratory & cardiovascular disease patient care, and consumer health technologies. The team of long-time collaborators was spurred to action when the novel Coronavirus spread across the globe leaving unparalleled infection, death, and economic destruction in its wake. Vironix’s core members knew that their collective understanding of chronic/viral disease progression and patient engagement technologies could produce healthcare solutions that would help to quell infection spread and improve wellness in businesses, schools, and hospitals around the world.